ranitidine has been researched along with Leukemia, Myeloid, Acute in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borthakur, G; Brail, L; Chow, KH; Cooley, S; Jackson, K; Moonan, L; Odenike, O; Rizzieri, DA; Wang, X | 1 |
Assa'ad, A; Burns, K; Hershey, GK; Johnson, T; Lierl, MB; Metz, KA; Seidu, L | 1 |
Brune, M; Hansson, M; Hellstrand, K; Hermodsson, S; Mellqvist, UH | 1 |
1 trial(s) available for ranitidine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Ulcer Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Bone Marrow Cells; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Female; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Maleimides; Middle Aged; Pain, Procedural; Pemetrexed; Protein Kinase Inhibitors; Ranitidine; Thrombocytopenia | 2016 |
2 other study(ies) available for ranitidine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
Topics: Cytarabine; Diphenhydramine; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylprednisolone; Premedication; Ranitidine; Syndrome; Treatment Outcome | 2009 |
NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
Topics: Catalase; CD56 Antigen; Cytotoxicity, Immunologic; Histamine; Histamine H2 Antagonists; Humans; Immunity, Cellular; Immunotherapy; Interferon-alpha; Interleukin-2; Killer Cells, Natural; Leukemia, Myeloid, Acute; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Ranitidine; Reactive Oxygen Species; Receptors, Histamine H2; Tumor Cells, Cultured | 1996 |